Beneficial effect of tachykinin NK1 receptor antagonism in the development of hapten-induced colitis in mice

European Journal of Pharmacology

Volumn 548, Issue 1-3, 2006, Pages 150-157

  Rijnierse, Anneke ^a   van Zijl, Kim M F ^a   Koster, Andries S ^a   Nijkamp, Frans P ^a   Kraneveld, Aletta D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

(Mice); Colitis; RP 67580; Substance P; Tachykinin NK1 receptor

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; HAPTEN; NATURAL KILLER CELL RECEPTOR; SUBSTANCE P; TACHYKININ;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; COLITIS; COLON INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; ENTERITIS; HYPERSENSITIVITY; HYPERTROPHY; LEUKOCYTE; LYMPHOID TISSUE; MALE; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; CAPILLARY PERMEABILITY; COLITIS; COLON; DIARRHEA; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; HAPTENS; HYPERSENSITIVITY; INDOLES; ISOINDOLES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, NEUROKININ-1; SUBSTANCE P; SULFONIC ACIDS;

EID: 33748702691     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.010     Document Type: Article

References (48)

1. Araki Y., Kakegawa T., and Stadil F. Mast cells and histamine release in Crohn's disease. Kurume Med. J. 40 (1993) 93-99
2. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3 (2003) 521-533
3. Columbo M., Horowitz E.M., Kagey-Sobotka A., and Lichtenstein L.M. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin. Immunol. Immunopathol. 81 (1996) 68-73
4. Croci T., Emonds-Alt X., Le Fur G., Maffrand J.P., and Manara L. The non-peptide tachykinin NK1- and NK2-receptor antagonists SR 140333 and SR 48968 prevent castor-oil induced diarrhea in rats. Acta Physiol. Hung. 84 (1996) 273-274
5. De Jonge F., Van Nassauw L., Adriaensen D., Van Meir F., Miller H.R., Van Marck E., and Timmermans J.P. Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice. Histochem. Cell Biol. 119 (2003) 477-484
6. Di Sebastiano P., Grossi L., Di Mola F.F., Angelucci D., Friess H., Marzio L., Innocenti P., and Buchler M.W. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig. Dis. Sci. 44 (1999) 439-444
7. Dohi T., Fujihashi K., Rennert P.D., Iwatani K., Kiyono H., and McGhee J.R. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J. Exp. Med. 189 (1999) 1169-1180
8. Ferry X., Brehin S., Kamel R., and Landry Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 23 (2002) 1507-1515
9. Galli S.J. Mast cells and basophils. Curr. Opin. Hematol. 7 (2000) 32-39
10. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.F., Blanchard J.C., and Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 10208-10212
11. Gurish M.F., and Austen K.F. The diverse roles of mast cells. J. Exp. Med. 194 (2001) F1-F5
12. He S.H. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 10 (2004) 309-318
13. Holzer P. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 59 (1998) 269-283
14. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol. Ther. 73 (1997) 219-263
15. Holzer P., and Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr. Opin. Pharmacol. 1 (2001) 583-590
16. Hubel K.A. Intestinal nerves and ion transport: stimuli, reflexes, and responses. Am. J. Physiol. 248 (1985) G261-G271
17. Jacobson K., McHugh K., and Collins S.M. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 109 (1995) 718-722
18. Kraneveld A.D., Buckley T.L., van Heuven-Nolsen D., van Schaik Y., Koster A.S., and Nijkamp F.P. Delayed-type hypersensitivity-induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade. Br. J. Pharmacol. 114 (1995) 1483-1489
19. Kraneveld A.D., van der Kleij H.P., Kool M., van Houwelingen A.H., Weitenberg A.C., Redegeld F.A., and Nijkamp F.P. Key role for mast cells in nonatopic asthma. J. Immunol. 169 (2002) 2044-2053
20. Lecci A., Capriati A., and Maggi C.A. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br. J. Pharmacol. 141 (2004) 1249-1263
21. Maggi C.A. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul. Pept. 93 (2000) 53-64
22. Malcangio M., and Bowery N.G. Peptide autoreceptors: does an autoreceptor for substance P exist?. Trends Pharmacol. Sci. 20 (1999) 405-407
23. Mantyh C.R., Vigna S.R., Bollinger R.R., Mantyh P.W., Maggio J.E., and Pappas T.N. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 109 (1995) 850-860
24. McCafferty D.M., Sharkey K.A., and Wallace J.L. Beneficial effects of local or systemic lidocaine in experimental colitis. Am. J. Physiol. 266 (1994) G560-G567
25. McCormack R.J., Hart R.P., and Ganea D. Expression of NK-1 receptor mRNA in murine T lymphocytes. Neuroimmunomodulation 3 (1996) 35-46
26. McKay D.M., and Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol. Today 15 (1994) 533-538
27. Moriarty D., Goldhill J., Selve N., O'Donoghue D.P., and Baird A.W. Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease. Br. J. Pharmacol. 133 (2001) 1346-1354
28. Moriarty D., Selve N., Baird A.W., and Goldhill J. Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation. Am. J. Physiol., Cell Physiol. 280 (2001) C852-C858
29. Niess J.H., Monnikes H., Dignass A.U., Klapp B.F., and Arck P.C. Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease. Digestion 65 (2002) 131-140
30. O'Connor T.M., O'Connell J., O'Brien D.I., Goode T., Bredin C.P., and Shanahan F. The role of substance P in inflammatory disease. J. Cell. Physiol. 201 (2004) 167-180
31. Poli E., Lazzaretti M., Grandi D., Pozzoli C., and Coruzzi G. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem. Res. 26 (2001) 1085-1093
32. Qian B.F., Zhou G.Q., Hammarstrom M.L., and Danielsson A. Both substance P and its receptor are expressed in mouse intestinal T lymphocytes. Neuroendocrinology 73 (2001) 358-368
33. Raithel M., Schneider H.T., and Hahn E.G. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 34 (1999) 496-503
34. Raithel M., Winterkamp S., Pacurar A., Ulrich P., Hochberger J., and Hahn E.G. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 36 (2001) 174-179
35. Renzi D., Pellegrini B., Tonelli F., Surrenti C., and Calabro A. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am. J. Pathol. 157 (2000) 1511-1522
36. Rijnierse A., Koster A.S., Nijkamp F.P., and Kraneveld A.D. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J. Immunol. 176 (2006) 4375-4384
37. Saban R., Nguyen N., Saban M.R., Gerard N.P., and Pasricha P.J. Nerve-mediated motility of ileal segments isolated from NK(1) receptor knockout mice. Am. J. Physiol. 277 (1999) G1173-G1179
38. Sibley D., and Jerrells T.R. Alcohol consumption by C57BL/6 mice is associated with depletion of lymphoid cells from the gut-associated lymphoid tissues and altered resistance to oral infections with Salmonella typhimurium. J. Infect. Dis. 182 (2000) 482-489
39. Stead R.H., Tomioka M., Quinonez G., Simon G.T., Felten S.Y., and Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 2975-2979
40. Stucchi A.F., Shofer S., Leeman S., Materne O., Beer E., McClung J., Shebani K., Moore F., O'Brien M., and Becker J.M. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am. J. Physiol.: Gastrointest. Liver Physiol. 279 (2000) G1298-G1306
41. Suzuki R., Furuno T., McKay D.M., Wolvers D., Teshima R., Nakanishi M., and Bienenstock J. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163 (1999) 2410-2415
42. Turvill J.L., Connor P., and Farthing M.J. Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum. Gastroenterology 119 (2000) 1037-1044
43. van der Kleij H.P., Kraneveld A.D., Redegeld F.A., Gerard N.P., Morteau O., and Nijkamp F.P. The tachykinin NK1 receptor is crucial for the development of non-atopic airway inflammation and hyperresponsiveness. Eur. J. Pharmacol. 476 (2003) 249-255
44. van der Kleij H.P., Ma D., Redegeld F.A., Kraneveld A.D., Nijkamp F.P., and Bienenstock J. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J. Immunol. 171 (2003) 2074-2079
45. van Loveren H., Meade R., and Askenase P.W. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157 (1983) 1604-1617
46. Watanabe T., Kubota Y., and Muto T. Substance P containing nerve fibers in ulcerative colitis. Int. J. Colorectal Dis. 13 (1998) 61-67
47. Weinstock J.V., Blum A., Metwali A., Elliott D., Bunnett N., and Arsenescu R. Substance P regulates Th1-type colitis in IL-10 knockout mice. J. Immunol. 171 (2003) 3762-3767
48. Yano H., Wershil B.K., Arizono N., and Galli S.J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J. Clin. Invest. 84 (1989) 1276-1286